3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
10
Burkitt Lymphoma
7
Lymphoma, Non-Hodgkin
5
Lung Neoplasms
5
Leukemia, Myeloid, Acute
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Carcinoma, Non-Small-Cell Lung
4
Recurrence
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Plasmablastic Lymphoma
3
Multiple Myeloma
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma
3
Leukemia
3
Hodgkin Disease
3
Sarcoma, Ewing
2
Myelodysplastic Syndromes
2
Lymphoproliferative Disorders
2
Lymphoma, T-Cell
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Immunoblastic Lymphadenopathy
2
HIV Infections
2
Ganglioneuroblastoma
2
Congenital Abnormalities
2
Blast Crisis
2
Anemia, Refractory, with Excess of Blasts
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Interventions
Specimen Handling
7
Magnetic Resonance Spectroscopy
7
Cisplatin
6
pembrolizumab
5
Carboplatin
5
durvalumab
4
Paclitaxel
4
Cetuximab
4
cemiplimab
3
Radiation
3
Platinum
3
Pemetrexed
3
Nivolumab
3
Docetaxel
3
Biopsy
3
1,2-diaminocyclohexaneplatinum II citrate
3
(225)Ac-DOTA-c(RGDyK)
3
cabozantinib
2
atezolizumab
2
Radiotherapy
2
Immunoglobulin G
2
Disulfides
2
ALT-803
2
130-nm albumin-bound paclitaxel
2
zipalertinib
1
trifluridine tipiracil drug combination
1
repotrectinib
1
regorafenib
1
poly ICLC
1
ipatasertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma
×
Etoposide
×
30 days
×
Clear all
No trials found.